Fresenius Medical Care Accelerates Second Tranche of Its EUR 1 Billion Share Buyback Program With Around EUR 415 Million Repurchase Planned
January 09, 2026
January 09, 2026
HOMBURG, Germany, Jan. 9 -- Fresenius Medical Care, a provider of products and services for people with chronic kidney failure, issued the following news release:
* * *
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
* The second tranche of the share buyback is expected to be executed by May 8, 2026
* The share buyback program with a total volume of . . .
* * *
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
* The second tranche of the share buyback is expected to be executed by May 8, 2026
* The share buyback program with a total volume of . . .